AI-generated summary
The authors randomized 18 patients with chronic diabetic foot wounds to a laser group or a control group and treated the laser group with 660 nm low-level laser therapy for four weeks. They report a significant difference in tissue repair index favoring the laser group, although PUSH scale scores did not differ between groups in any week. The authors conclude the treatment showed efficacy over a short period.
- Participants
- 18
- Who or what was studied
- Patients aged 30 to 59 years with chronic wounds on the foot due to diabetes mellitus complications
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract describes a small sample of 18 patients and does not report a blinding method or long-term follow-up, and PUSH scores showed no significant group difference.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 6 J/cm2
- Power
- 30 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group, Wavelength, Dosimetry. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.